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In the present study, liquid chromatography coupled to an Orbitrap mass spectrometer (HPLC–
Q-Orbitrap MS) was used as an approach for identification and quantification of 113 drugs 
simultaneously in biological samples (whole blood/plasma/serum). Samples were prepared 
using liquid–liquid extraction conducted using a trizma/isopropanol/butyl chloride buffer 
system. Reversed-phase separation employing a column (50 × 2.1 mm) packed with 2.6-μm C18 
particles was then performed under gradient elution with mobile phase composition consisting 
of acetic acid and aqueous-acetonitrile mixtures with the acetonitrile content ranging from 10 
to 100% v/v. Compounds were detected with high-resolution MS operated in full scan mode 
having a mass accuracy < 5 ppm. In this study, isobaric compounds (same nominal mass) were 
easily distinguished and identified by their different retention times. Extracted ion 
chromatograms (XICs) with narrow mass tolerance window (5 ppm) provided analysis with 
acceptable linearity (r2) ranged from 0.9530 to 1, low limits of detection (LOD) (0.02–
39 ng mL−1) and low limit of quantification (LOQ) (0.1–130 ng mL−1). The developed method was 
applied to successfully analyse drugs in 26 blood samples from positive forensic cases and 
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